Occasional Digest

Ionis gains approval of zilganersen for Alexander disease (NASDAQ:IONS)

FDA Approved Stamp

Getty Images

  • The US FDA on Thursday approved Ionis Pharmaceuticals’ (IONS) Zanvastro (zilganersen) as the first-ever treatment for Alexander disease.
  • The antisense oligonucleotide won approval based on results of a randomized, controlled study of pediatric and adult patients with the condition two years of age and older, and in

Source link

Exit mobile version